Hypertensive Disorders of Pregnancy and Offspring Cardiac Structure and Function in Adolescence

Simon Timpka1, Corrie Macdonald-Wallis2,3, Alun D Hughes4

  • 1Genetic and Molecular Epidemiology Unit, Lund University Diabetes Center, Lund University, Malmö, Sweden simon.timpka@med.lu.se.

Insights

Maternal preeclampsia and gestational hypertension during pregnancy are linked to altered adolescent offspring cardiac structure. These changes, including increased relative wall thickness, may signal future cardiovascular disease risk.

Area of Science:

  • Cardiovascular Science
  • Developmental Biology
  • Public Health

Background:

  • Fetal exposure to preeclampsia is linked to elevated blood pressure and stroke risk later in life.
  • Hypertensive disorders of pregnancy may impact offspring cardiovascular development.
  • Understanding these long-term effects is crucial for preventative healthcare.

Purpose of the Study:

  • To investigate associations between maternal hypertensive disorders of pregnancy and offspring cardiac structure and function in adolescence.
  • To examine the impact of maternal blood pressure changes during pregnancy on adolescent offspring cardiovascular outcomes.

Main Methods:

  • Prospective birth cohort study including 1592 offspring at mean age 17.7 years.
  • Echocardiography used to assess offspring cardiac structure and function.
  • Linear regression and multilevel linear spline models analyzed associations with maternal preeclampsia, gestational hypertension, and blood pressure changes.

Main Results:

  • Maternal preeclampsia and gestational hypertension were associated with increased offspring relative wall thickness.
  • Preeclampsia exposure was linked to smaller left ventricular end-diastolic volume in offspring.
  • No significant associations were found between hypertensive disorders of pregnancy and offspring cardiac function.

Conclusions:

  • Adolescent offspring exposed to maternal preeclampsia exhibit cardiac structural changes, including greater relative wall thickness and reduced left ventricular end-diastolic volume.
  • These findings suggest potential early signs of concentric remodeling, which could influence future cardiovascular health.
  • Further research is warranted to understand the long-term implications for cardiovascular disease risk.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
690
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
607